Get started

Cardiovascular Research Foundation

Homepage: crf.org
ROR: 04yxwc698
OpenAlex ID: I4210144653
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 · Bertram Pitt, Faiez Zannad, et al. · New England Journal of Medicine · 9,176
PDF
Clinical End Points in Coronary Stent Trials
2007 · Donald E. Cutlip, Stephan Windecker, et al. · Circulation · 5,499
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 · Christian T Ruff, Robert P Giugliano, et al. · The Lancet · 5,042
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 · Bertram Pitt, Willem Remme, et al. · New England Journal of Medicine · 4,955
PDF
Post-acute COVID-19 syndrome
2021 · Ani Nalbandian, Kartik Sehgal, et al. · Nature Medicine · 4,850
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 · Roxana Mehran, Sunil V. Rao, et al. · Circulation · 4,476
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
2003 · Jeffrey W. Moses, Martin B. Leon, et al. · New England Journal of Medicine · 4,224
PDF
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 · Gregg W. Stone, Akiko Maehara, et al. · New England Journal of Medicine · 3,277
PDF
Extrapulmonary manifestations of COVID-19
2020 · Aakriti Gupta, Mahesh V. Madhavan, et al. · Nature Medicine · 3,176
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 · Gregg W. Stone, JoAnn Lindenfeld, et al. · New England Journal of Medicine · 2,999
PDF
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
2000 · BERTRAM PITT, FAIEZ ZANNAD, et al. · Survey of Anesthesiology · 2,927
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
2020 · Behnood Bikdeli, Mahesh V. Madhavan, et al. · Journal of the American College of Cardiology · 2,885
PDF
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 · Gregg W. Stone, Stephen G. Ellis, et al. · New England Journal of Medicine · 2,749
PDF
Initial Invasive or Conservative Strategy for Stable Coronary Disease
2020 · David J. Maron, Judith S. Hochman, et al. · New England Journal of Medicine · 2,450
PDF
A Controlled Trial of Renal Denervation for Resistant Hypertension
2014 · Deepak L. Bhatt, David E. Kandzari, et al. · New England Journal of Medicine · 2,189
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
2004 · Roxana Mehran, Eve D. Aymong, et al. · Journal of the American College of Cardiology · 2,044
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
2020 · Elissa Driggin, Mahesh V. Madhavan, et al. · Journal of the American College of Cardiology · 2,017
PDF
Strategies for Multivessel Revascularization in Patients with Diabetes
2012 · Michael E. Farkouh, Michael Domanski, et al. · New England Journal of Medicine · 1,922
PDF
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 · Gregg W. Stone, Bernhard Witzenbichler, et al. · New England Journal of Medicine · 1,867
PDF
Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
2007 · Gregg W. Stone, Jeffrey W. Moses, et al. · New England Journal of Medicine · 1,631
PDF
Bivalirudin for Patients with Acute Coronary Syndromes
2006 · Gregg W. Stone, Brent T. McLaurin, et al. · New England Journal of Medicine · 1,459
PDF
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
2007 · Christoph Stettler, Simon Wandel, et al. · The Lancet · 1,428
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
2021 · Philippe Généreux, Nicolo Piazza, et al. · Journal of the American College of Cardiology · 1,315
PDF
Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction
2002 · Gregg W. Stone, Cindy L. Grines, et al. · New England Journal of Medicine · 1,277
PDF
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation
2004 · R MEHRAN, E AYMONG, et al. · Journal of the American College of Cardiology · 1,251
Works count: 5,571
Citation count: 1,559,000
Year
Topic
Type